Carborane Hydrophobic Tags Drive Selective Degradation of Endogenous KRASG12C via HSP70-Ubiquitin-Proteasome Pathway

Yujie Shao1,2, Kazuki Miura1,2, Hiroyuki Nakamura1,2

  • 1School of Life Science and Technology, Institute of Science Tokyo, 4259 Nagatsuta-cho Midori-ku, Yokohama 226-8501, Japan.

ACS Bio & Med Chem Au
|June 22, 2026
PubMed

Insights

Researchers developed novel carborane-based degraders (HY8) that selectively eliminate Kirsten rat sarcoma viral oncogene homologue (KRAS)G12C. This approach offers a new strategy for targeting oncogenic KRAS proteins and suppressing cancer signaling pathways.

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Discovery

Background:

  • Persistent activation of KRASG12C mutations drives oncogenic signaling in various cancers.
  • Existing covalent inhibitors for KRASG12C may lead to incomplete pathway suppression or drug resistance.

Purpose of the Study:

  • To develop novel hydrophobic-tag (HyT) degraders for selective elimination of endogenous KRASG12C.
  • To investigate the mechanism of action and efficacy of carborane-HyT conjugates (HY8) against KRASG12C.

Main Methods:

  • Development of carborane-HyT conjugates (HY8) by incorporating a carborane cluster into an MRTX849 KRASG12C covalent ligand.
  • Assessment of KRASG12C abundance, ERK phosphorylation, and cytotoxicity in mutant cancer cells.
  • Mechanistic studies involving proteasome and lysosomal inhibitors, ubiquitination assays, and heat shock protein 70 engagement.

Main Results:

  • Carborane-HyT conjugates (HY8) effectively reduced KRASG12C abundance and ERK phosphorylation.
  • HY8 demonstrated lower intrinsic cytotoxicity compared to analogues, with equal or superior activity.
  • Degradation occurred via an E3 ligase-independent, chaperone-assisted, proteasome-dependent pathway, confirmed by resistance to lysosomal inhibition and rescue by proteasome inhibition.

Conclusions:

  • Carborane serves as a functional hydrophobic tag for driving proteasome-dependent degradation of endogenous KRASG12C.
  • This study broadens degrader design strategies to include E3-independent modalities for targeting oncogenic proteins.
  • The developed HY8 conjugates represent a promising therapeutic strategy for cancers driven by KRASG12C mutations.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...